TScan Therapeutics TCRX
NASDAQ TCRX
$0.78 +0.00 (+0.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021)

TScan Therapeutics (TCRX) posted quarterly Treasury Shares of $116870.0 for Q4 2021, down 98.35% year-over-year from $7.1 million in Q4 2020, and down 42.85% quarter-over-quarter from $204513.0 in Q3 2021.

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021) Analysis & Trends

TScan Therapeutics (TCRX) has reported Treasury Shares for 2 consecutive years, with $116870.0 the latest figure, recorded in Q4 2021.

  • In Q4 2021, Treasury Shares fell 98.35% year-over-year to $116870.0; the TTM figure through Dec 2021 stood at $116870.0 (down 98.35% YoY), while the FY2021 annual figure was $116870.0, down 98.35% from the prior year.
  • Treasury Shares eased to $116870.0 in Q4 2021 per TCRX's latest filing, from $204513.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $15.6 million in Q1 2021 and bottomed at $116870.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.96 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 2.72 Mn
10 TScan Therapeutics 100.62 Mn 100.62 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 116,870.00
Dec 31, 2021 116,870.00
Sep 30, 2021 204,513.00
Sep 30, 2021 204,513.00
Jun 30, 2021 15.62 Mn
Jun 30, 2021 15.62 Mn
Mar 31, 2021 15.62 Mn
Mar 31, 2021 15.62 Mn
Dec 31, 2020 7.06 Mn
Dec 31, 2020 7.06 Mn
Sep 30, 2020 7.06 Mn
Sep 30, 2020 7.06 Mn
Jun 30, 2020 7.06 Mn
Jun 30, 2020 7.06 Mn